The essential MPN high throughput panel is a robust and reproducible assay using blood, bone marrow and cell pellet. The molecular alterations detected by this assay can assist in diagnosis, prognosis and making cancer treatment decisions involving targeted therapies in a clinically relevant turn-around time.